Sernova (TSE:SVA) Sets New 52-Week Low – Should You Sell?

Shares of Sernova Corp. (TSE:SVAGet Free Report) hit a new 52-week low during trading on Monday . The company traded as low as C$0.15 and last traded at C$0.16, with a volume of 4850 shares. The stock had previously closed at C$0.15.

Sernova Trading Up 9.1 %

The company has a quick ratio of 18.11, a current ratio of 0.32 and a debt-to-equity ratio of -4.40. The firm has a market cap of C$60.57 million, a P/E ratio of -1.74 and a beta of 1.35. The firm’s fifty day moving average is C$0.19 and its two-hundred day moving average is C$0.22.

Sernova Company Profile

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Featured Stories

Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.